Search results
Geron surges after winning first US FDA approval for blood disorder drug
Reuters· 7 days ago, opens new tab surged more than 30% on Friday, a day after the company gained its first approval...
When "abortion travel" becomes a nightmare: A tale of no good choices
Salon via Yahoo News· 2 days agodisorders. The results of the test took slightly longer than normal to come back, and when they did,...
Fight over secret N.J. ‘baby blood stockpile’ may be headed to court after talks stall
NJ.com· 6 days agoWhen babies are born in New Jersey, they don’t wait long before they take their very first test....
Geron surges after winning first US FDA approval for blood disorder drug By Reuters
Investing.com· 7 days agoThe health regulator's nod allows the injectable drug, branded as Rytelo, to be used for treating...
POEMS Syndrome
Health via Yahoo News· 6 days agoThese two symptom types are "mandatory major criteria" for diagnosing the condition. POEMS syndrome is often diagnosed by a neurologist (doctor...
Geron surges after winning first US FDA approval for blood disorder drug
AOL· 7 days ago(Reuters) -Shares of Geron surged more than 20% on Friday, a day after the company gained its first approval from the U.S. Food and Drug Administration for its blood
Long Islander has donated nearly 29 gallons of blood since 1975 — enough to fill 310 soda cans
NY Post metro via AOL· 6 days agoHenry Bickoff, 68, of Huntington, LI, has donated 231 pints of blood — one donation shy of 29...
11 Symptoms of Paranoid Personality Disorder
Health.com· 6 days agoParanoid personality disorder (PPD) is a mental health condition that causes a pattern of suspicion and mistrust of other people, even without enough...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 17 hours agoIt's why Dupixent treats seemingly different conditions like eczema, asthma and chronic nasal...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 14 hours agoInstead, Lykos conducted trials that ignored the agency’s recommendations and failed to follow best...
